These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 30324346)

  • 1. Advances in Radiotherapy for Prostate Cancer Treatment.
    Podder TK; Fredman ET; Ellis RJ
    Adv Exp Med Biol; 2018; 1096():31-47. PubMed ID: 30324346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of HDR brachytherapy-replicating prostate radiotherapy planning for tomotherapy, cyberknife and VMAT.
    de Chavez R; Grogan G; Hug B; Howe K; Grigg A; Waterhouse D; Lane J; Glyde A; Brown E; Bydder S; Pryor D; Hargrave C; Charles PH; Hellyer J; Ebert MA
    Med Dosim; 2022 Spring; 47(1):61-69. PubMed ID: 34551879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiation-induced second primary cancer risks from modern external beam radiotherapy for early prostate cancer: impact of stereotactic ablative radiotherapy (SABR), volumetric modulated arc therapy (VMAT) and flattening filter free (FFF) radiotherapy.
    Murray LJ; Thompson CM; Lilley J; Cosgrove V; Franks K; Sebag-Montefiore D; Henry AM
    Phys Med Biol; 2015 Feb; 60(3):1237-57. PubMed ID: 25590229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosimetric Comparison and Evaluation of 4 Stereotactic Body Radiotherapy Techniques for the Treatment of Prostate Cancer.
    Seppälä J; Suilamo S; Tenhunen M; Sailas L; Virsunen H; Kaleva E; Keyriläinen J
    Technol Cancer Res Treat; 2017 Apr; 16(2):238-245. PubMed ID: 28279147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dosimetric considerations to determine the optimal technique for localized prostate cancer among external photon, proton, or carbon-ion therapy and high-dose-rate or low-dose-rate brachytherapy.
    Georg D; Hopfgartner J; Gòra J; Kuess P; Kragl G; Berger D; Hegazy N; Goldner G; Georg P
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):715-22. PubMed ID: 24521685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose fall-off patterns with volumetric modulated arc therapy and three-dimensional conformal radiotherapy including the "organ at risk" effect. Experience of linear accelerator-based frameless radiosurgery from a single institution.
    Munshi A; Sarkar B; Roy S; Ganesh T; Mohanti BK
    Cancer Radiother; 2019 Apr; 23(2):138-146. PubMed ID: 30797691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secondary cancer risk from modern external-beam radiotherapy of prostate cancer patients: Impact of fractionation and dose distribution.
    Sitathanee C; Tangboonduangjit P; Dhanachai M; Suntiwong S; Yongvithisatid P; Rutchantuk S; Changkaew P; Watjiranon R; Khachonkham S; Boonkitticharoen V
    J Radiat Res; 2021 Jul; 62(4):707-717. PubMed ID: 33993271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging technologies in stereotactic body radiotherapy.
    Ma L; Wang L; Tseng CL; Sahgal A
    Chin Clin Oncol; 2017 Sep; 6(Suppl 2):S12. PubMed ID: 28917250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Volumetric modulated arc therapy (VMAT) vs. serial tomotherapy, step-and-shoot IMRT and 3D-conformal RT for treatment of prostate cancer.
    Wolff D; Stieler F; Welzel G; Lorenz F; Abo-Madyan Y; Mai S; Herskind C; Polednik M; Steil V; Wenz F; Lohr F
    Radiother Oncol; 2009 Nov; 93(2):226-33. PubMed ID: 19765846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of three dimensional conformal radiation therapy, intensity modulated radiation therapy and volumetric modulated arc therapy for low radiation exposure of normal tissue in patients with prostate cancer.
    Cakir A; Akgun Z; Fayda M; Agaoglu F
    Asian Pac J Cancer Prev; 2015; 16(8):3365-70. PubMed ID: 25921146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accuracy of real-time couch tracking during 3-dimensional conformal radiation therapy, intensity modulated radiation therapy, and volumetric modulated arc therapy for prostate cancer.
    Wilbert J; Baier K; Hermann C; Flentje M; Guckenberger M
    Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):237-42. PubMed ID: 22541958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intensity modulated proton and photon therapy for early prostate cancer with or without transperineal injection of a polyethylen glycol spacer: a treatment planning comparison study.
    Weber DC; Zilli T; Vallee JP; Rouzaud M; Miralbell R; Cozzi L
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):e311-8. PubMed ID: 22999271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hippocampal-sparing and target volume coverage in treating 3 to 10 brain metastases: A comparison of Gamma Knife, single-isocenter VMAT, CyberKnife, and TomoTherapy stereotactic radiosurgery.
    Zhang I; Antone J; Li J; Saha S; Riegel AC; Vijeh L; Lauritano J; Marrero M; Salas S; Schulder M; Zinkin H; Goenka A; Knisely J
    Pract Radiat Oncol; 2017; 7(3):183-189. PubMed ID: 28477798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of RapidArc volumetric-modulated arc therapy to deliver stereotactic radiosurgery and stereotactic body radiotherapy to intracranial and extracranial targets.
    Roa DE; Schiffner DC; Zhang J; Dietrich SN; Kuo JV; Wong J; Ramsinghani NS; Al-Ghazi MS
    Med Dosim; 2012; 37(3):257-64. PubMed ID: 22365418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of dose distribution and risk of pneumonitis in stereotactic body radiation therapy for centrally located lung tumors: a comparison of robotic radiosurgery, helical tomotherapy and volumetric modulated arc therapy.
    Kannarunimit D; Descovich M; Garcia A; Chen J; Weinberg V; Mcguinness C; Pinnaduwage D; Murnane J; Gottschalk AR; Yom SS
    Technol Cancer Res Treat; 2015 Feb; 14(1):49-60. PubMed ID: 24325136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosimetric comparison of helical tomotherapy, intensity-modulated radiation therapy, volumetric-modulated arc therapy, and 3-dimensional conformal therapy for the treatment of T1N0 glottic cancer.
    Ekici K; Pepele EK; Yaprak B; Temelli O; Eraslan AF; Kucuk N; Altınok AY; Sut PA; Alpak OD; Colak C; Mayadagli A
    Med Dosim; 2016 Winter; 41(4):329-333. PubMed ID: 27765542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Feasibility and Efficiency of Volumetric Modulated Arc Therapy-Based Breath Control Stereotactic Body Radiotherapy for Liver Tumors.
    Qiu JJ; Ge W; Zhang L; Yao Y; Zheng X
    Technol Cancer Res Treat; 2016 Oct; 15(5):674-82. PubMed ID: 26206766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton arc reduces range uncertainty effects and improves conformality compared with photon volumetric modulated arc therapy in stereotactic body radiation therapy for non-small cell lung cancer.
    Seco J; Gu G; Marcelos T; Kooy H; Willers H
    Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):188-94. PubMed ID: 23920395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosimetric characterization of hypofractionated Gamma Knife radiosurgery of large or complex brain tumors versus linear accelerator-based treatments.
    Dong P; Pérez-Andújar A; Pinnaduwage D; Braunstein S; Theodosopoulos P; McDermott M; Sneed P; Ma L
    J Neurosurg; 2016 Dec; 125(Suppl 1):97-103. PubMed ID: 27903198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Recent developments in radiation oncology-integrating radiation physics and molecular radiobiology advances into clinical radiotherapy practice and beyond].
    Teh BS; Paulino A; Butler EB
    Ai Zheng; 2008 Aug; 27(8):885-93. PubMed ID: 18710628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.